A new drug developed by scientists at the Florey Institute of Neuroscience, and the School of Chemistry and Bio21 Institute at the University of Melbourne has dramatically improved clinical and cognitive symptoms of motor neurone disease, also called amyotrophic lateral sclerosis.
Motor neurone disease is a progressive, fatal neurodegenerative disease. Its key hallmark is the death of the brain cells that control muscle movements. This results in muscle weakness and eventually paralysis.
Patients usually die of respiratory failure within three years of diagnosis, and there are no treatments or disease-modifying therapies available.
In this dose-finding trial involving 32 patients, the group given the highest amount of the CuATSM compound showed improved lung function and cognitive ability, compared to the predicted declines observed in standard-of-care patients.
Further, treated patients showed a much slower overall disease progression as measured by a global disability score.
The clinical trial was led by Professor Dominic Rowe at Macquarie University, and Associate Professor Susan Mathers at Calvary Health Care Bethlehem, and sponsored by Collaborative Medicinal Development Pty Ltd with support from FightMND.
Professor Ashley Bush, Chief Scientific Officer of Collaborative Medicinal Development and director of the Melbourne Dementia Research Centre, said “This is the first human evidence for a disease-modifying drug for motor neurone disease. It is a huge breakthrough, and we look forward to confirming the positive results in a larger study soon.”
Associate Professor Kevin Barnham of the Florey, Associate Professor Anthony White at the Queensland Institute of Medical Research, and Professor Paul Donnelly and Associate Professor Peter Crouch from the University of Melbourne, developed and tested CuATSM over a 15-year period.
After showing its therapeutic potential for motor neurone disease in pre-clinical models, the researchers founded a company and licenced the compound to Collaborative Medicinal Development, to take the drug into human studies.
Professor Donnelly said, “It is gratifying to see such promising results made possible by collaborative fundamental research at the interface between chemistry and biology.”
Learn more: Motor neurone disease breakthrough: Patient trial shows impressive clinical results
The Latest on: Motor neurone disease
[google_news title=”” keyword=”motor neurone disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Motor neurone disease
- ‘Game-changer’ test spots signs of motor neurone disease before symptoms – studyon March 28, 2024 at 1:29 am
A test that spots signs of motor neurone disease before symptoms appear has been hailed a “game changer” by scientists developing it.The tool, known as TDP-43 aptamer, is able to detect damaged cell ...
- Motor neurone disease breakthrough as test spots signs even before symptomson March 27, 2024 at 9:06 pm
A test that spots signs of motor neurone disease before symptoms appear has been hailed a “game changer” by scientists developing it. The tool, known as TDP-43 aptamer, is able to detect damaged cell ...
- 'Game changer' test could spot signs of motor neurone disease earlieron March 27, 2024 at 6:41 pm
The research has "exciting potential" to diagnose people earlier - which could make treatments more effective, says the Motor Neurone Disease Association.
- New 'game-changer' test spots motor neurone disease before symptoms appearon March 27, 2024 at 5:15 pm
A test that spots signs of motor neurone disease before symptoms appear has been hailed a “game changer” by scientists developing it. The tool, known as TDP-43 aptamer, is able to detect damaged cell ...
- New 'gamer changer' test spots signs of motor neurone disease before symptoms appearon March 27, 2024 at 5:01 pm
A test that spots signs of motor neurone disease before symptoms appear has been hailed a "game changer" by scientists developing it. The tool, known as TDP-43 aptamer, is able to detect damaged cell ...
- Irish Motor Neurone Disease Association receives €500,000 funding from JP McManus Foundationon March 25, 2024 at 10:46 am
The JP McManus Foundation has provided a €500,000 boost to the work of the Irish Motor Neurone Disease Association (IMNDA). The large donation by the foundation named after the billionaire Limerick ...
- Former Lionesses captain Steph Houghton pushes husband Stephen Darby, 35, in a wheelchair on 178-mile walk to fight Motor Neuron Disease - as pair raise £130,000 to combat ...on March 25, 2024 at 6:55 am
Former England captain Steph Houghton was joined by a host of footballing royalty as she pushed her husband Stephen Darby in a wheelchair to raise awareness for Motor Neurone Disease, which ended ...
- Pembrokeshire mum facing heartbreaking motor neurone disease battleon March 23, 2024 at 7:00 pm
Five brothers from north Pembrokeshire are taking on a series of challenges to show support and solidarity with their mum, who has Motor Neurone Disease (MND), and to thank a charity that has ...
- Tributes pour in following the death of former inter-county GAA star, 44, after Motor Neurone Disease battleon March 23, 2024 at 11:37 am
Ger Brady was diagnosed with the disease in August of 2022 and represented Mayo at Minor, U21 and Senior level ...
- ‘Adventure was in my blood and I always wanted more’: kayaker Adrian Harkin on his motor neurone disease diagnosison March 22, 2024 at 6:30 pm
This is not a story I want to tell. I baulk at the writing of it, rail against the words as they land one at a time. But my friend Adrian Harkin has asked me to share some of his adventures and the ...
via Bing News